Retatrutide
Next generation triple receptor research peptide for metabolic pathway studies. 10mg vial, 99%+ purity, third party tested.
About This Product
Retatrutide is a next generation research peptide that targets three receptors simultaneously: GLP-1, GIP, and glucagon. This triple action mechanism makes it one of the most studied compounds in current metabolic research. Early clinical trials have shown significant results in body composition studies, making it a leading focus for researchers investigating weight management pathways.
Each vial contains 10mg of lyophilized (freeze dried) Retatrutide at 99%+ purity, verified by third party testing. Certificate of Analysis available for download above.
Store lyophilized at -20°C for up to 24 months. Once reconstituted with bacteriostatic water, store at 2 to 8°C and use within 30 days.
Compound Information
What Is Retatrutide?
| Type | Synthetic Peptide |
| Targets | GLP-1, GIP, Glucagon receptors |
| Molecular Weight | ~4,300 Da |
| Amino Acids | 39 |
| Classification | Triple agonist |
| Purity | 99%+ |
Stability Information
Sources & References
Peer-reviewed research
⚠ Important Research Notice
Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.
All clinical trial data and research findings presented on this page are sourced from peer-reviewed journals and official publications. They are provided for educational reference only and should not be interpreted as medical advice or product claims.
By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.
